化学療法装置市場：製品タイプ、モダリティ、用途、エンドユーザー別-2025-2030年の世界予測

化学療法装置市場は、2024年には203億米ドルとなり、2025年には217億4,000万米ドル、CAGR 7.27%で成長し、2030年には309億4,000万米ドルに達すると予測されています。

急速に進化する今日のヘルスケア情勢において、化学療法機器市場は、絶え間ないイノベーションと患者ケアの強化に牽引され、注目すべき変貌を遂げています。本レポートでは、高度な化学療法機器への嗜好の高まりの背景にある要因について掘り下げ、精密治療と患者の快適性の向上に焦点が当てられていることに注目しています。本サマリーでは、主要な業界動向、技術的ブレークスルー、市場を形成しているダイナミックな規制環境について詳細に分析しています。がん罹患率の上昇と個別化ヘルスケアソリューションへの需要の高まりにより、組織は治療方法の再考と改革を進めています。本レポートでは、効果的で患者に優しい治療法に対するニーズの高まりが、最先端の化学療法機器の開発と普及にどのような影響を及ぼしているかについて、包括的な解説を利害関係者に提供します。

この市場は、研究開発への多額の投資によって、技術的に先進的であるだけでなく、より高い臨床精度と安全性プロファイルをサポートするように設計されたデバイスを生み出しています。この入門的な概要は、市場の様々な側面への洞察に満ちた旅の舞台を設定し、業界の専門家と意思決定者の双方に、化学療法機器分野における現在および将来の戦略を方向付ける重要な要因を探るよう促すものです。

化学療法装置市場の変革

化学療法機器市場の進化は、従来の治療パラダイムを変えつつある変革的なシフトによって推進されています。今日、医療技術の進歩は、研究機関とメーカーの戦略的提携とともに、技術革新のための肥沃な環境を作り出しています。この進化の特徴は、従来の画一的な治療レジメンから、患者個々の要求に応える個別化された適応的アプローチへの移行です。

このシフトの中心にあるのは、デジタル技術とデータ分析の統合であり、機器性能の精度と信頼性を高めるものです。小型化における技術革新は、非常に効率的であるだけでなく、持ち運びも可能な機器への道を開き、臨床医が多様な環境で治療を実施できるようにしました。さらに、デザインと機能性の継続的な改善により、機器の使用に伴う合併症が減少し、次世代治療法の採用が促進されています。

このような変化は、バリュー・ベース・ケア（治療結果の改善、コスト効率、患者満足度の向上を重視するモデル）に向けた幅広い動向を反映しています。これらの開発により、治療の提供方法に変革がもたらされ、よりダイナミックで迅速なヘルスケアシステムが構築されつつあります。この転換は、患者の安全性を確保しつつイノベーションをますます優先させる規制の変更によって支えられており、市場成長のための強固な環境づくりに貢献しています。このような統合的な進歩を通じて、業界は、敏捷性と情報に基づいた正確さで、将来のヘルスケア需要の課題に対応する準備が整っています。

デバイス市場の詳細なセグメンテーション洞察

市場を徹底的に調査することで、化学療法装置の多様な側面を理解する上で極めて重要な、階層的なセグメンテーション戦略が明らかになります。製品タイプの分析では、カテーテル、埋め込み型ポート、輸液ポンプ、ニードルレスコネクターなどの重要なセグメントを網羅しています。注目すべきは、カテーテルセグメントを中心静脈カテーテル、末梢カテーテル、末梢挿入型中心静脈カテーテルに分解し、ニュアンスの異なるレンズを通して調査していることです。同様に、輸液ポンプのカテゴリーも、外来用ポンプ、エラストマーポンプ、シリンジポンプ、容量ポンプなどのサブセグメントに拡大しています。このような詳細な製品分類は、特定の患者のニーズへの対応や臨床転帰の改善に役立っており、メーカーの精度と技術革新へのコミットメントを示しています。

モダリティに基づくセグメンテーションは、ポータブル機器と据置型機器を区別し、市場分析をさらに豊かにします。この分類は、緊急介入から管理された環境での日常的な長期治療まで、多様な臨床状況に対応することを目的とした技術的進歩を浮き彫りにしています。機器の携帯性の程度は、治療へのアクセスや利便性に影響するため特に重要であり、それによって患者のアドヒアランスや快適性に直接影響します。

セグメンテーションのもう一つの重要な側面は、用途に基づくものです。ここでは、乳がん、大腸がん、白血病、肺がん、前立腺がんなど、さまざまな種類のがんの治療プロトコルを対象としています。各がん種には固有の臨床課題と治療アプローチがあり、特定の医学的・解剖学的要件に合わせた機器が必要となります。アプリケーションの分析により、正確な薬剤投与をサポートするだけでなく、治療サイクル全体を通じて安全で効率的な患者ケアを促進する機器を設計することの重要性が強調されています。

さらに、化学療法装置が使用される医療環境の多様性を強調する側面として、エンドユーザーに焦点を当てたセグメンテーションも行っています。外来手術センターから在宅ケア環境、病院まで、これらの機器の使用はさまざまなヘルスケア提供モデルに適応しています。それぞれのエンドユーザー・カテゴリーには、独自の運用上のニーズと臨床上の期待があり、効率性と堅牢な安全機能を融合させた機器が求められます。このセグメンテーションのフレームワークにより、メーカーとヘルスケアプロバイダーは、各医療環境の詳細な要求に合わせて製品を提供することができ、その結果、より患者中心のアプローチが可能になります。

これらのセグメンテーションの洞察を統合することで、市場を包括的に捉えることができます。独自のサブカテゴリーと特定の臨床用途を持つ各セグメントは、革新的な化学療法機器の全体的な採用と成功を促進する上で極めて重要な役割を果たしています。製品タイプ、モダリティ、アプリケーション、およびエンドユーザーの微妙な解釈は、市場の高度化と業界利害関係者に待ち受ける幅広い機会を浮き彫りにします。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的にがんの罹患率が増加し、診断率が拡大している
    • 先進医療へのアクセス向上のためのヘルスケア費増加
    • 個別化および標的治療アプローチの重要性の高まり
  • 抑制要因
    • 高度な化学療法機器の高コストと代替治療技術の利用可能性
  • 機会
    • 標的化学療法送達システムの開発における革新
    • 化学療法装置における人工知能と機械学習の統合
  • 課題
    • 化学療法機器の安全性に関する懸念と潜在的な副作用
• 市場セグメンテーション分析
  • 製品タイプ：挿入の容易さと低侵襲性により末梢カテーテルの需要が増加
  • エンドユーザー：低侵襲手術をサポートするために外来手術センターで化学療法装置の使用が増加している
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 化学療法装置市場：製品タイプ別

• カテーテル
  • 中心静脈カテーテル
  • 末梢カテーテル
  • 末梢挿入型中心静脈カテーテル
• 埋め込み型ポート
• 輸液ポンプ
  • 歩行用ポンプ
  • エラストマーポンプ
  • シリンジポンプ
  • 容積式ポンプ
• ニードルレスコネクタ

第7章 化学療法装置市場：モダリティ別

• ポータブルデバイス
• 据置型デバイス

第8章 化学療法装置市場：用途別

• 乳がん
• 大腸がん
• 白血病
• 肺がん
• 前立腺がん

第9章 化学療法装置市場：エンドユーザー別

• 外来手術センター
• 在宅ケア設定
• 病院

第10章 南北アメリカの化学療法装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の化学療法装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの化学療法装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AngioDynamics, Inc.
• Avanos Medical, Inc.
• B. Braun SE
• Baxter International,
• Becton, Dickinson and Company
• Belmont Medical, Inc.
• CODAN Medizinische Gerate GmbH
• Districlass Medical SA
• F. Hoffmann-La Roche Ltd
• ICU Medical, Inc.
• InfuSystems, Inc.
• Leventon S.A.U.
• Micrel Medical Devices SA
• Mindray Medical International Limited
• Moog Inc.
• Nipro Corporation
• Omnicell Inc.
• Poly Medicure Limited
• Schiller AG
• Smiths Group plc.
• Terumo Corporation
• ThermaSolutions
• Ypsomed AG
• Zyno Medical LLC.

LIST OF FIGURES

• FIGURE 1. CHEMOTHERAPY DEVICE MARKET MULTI-CURRENCY
• FIGURE 2. CHEMOTHERAPY DEVICE MARKET MULTI-LANGUAGE
• FIGURE 3. CHEMOTHERAPY DEVICE MARKET RESEARCH PROCESS
• FIGURE 4. CHEMOTHERAPY DEVICE MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. CHEMOTHERAPY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. CHEMOTHERAPY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. CHEMOTHERAPY DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CHEMOTHERAPY DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PERIPHERAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY IMPLANTABLE PORTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY AMBULATORY PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY NEEDLELESS CONNECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 55. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 57. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 87. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 88. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 89. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 93. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 94. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 95. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 196. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 197. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 198. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 220. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 221. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 222. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 226. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 227. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 228. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. CHEMOTHERAPY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 285. CHEMOTHERAPY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

The Chemotherapy Device Market was valued at USD 20.30 billion in 2024 and is projected to grow to USD 21.74 billion in 2025, with a CAGR of 7.27%, reaching USD 30.94 billion by 2030.

In today's rapidly evolving healthcare landscape, the chemotherapy device market is experiencing a noteworthy transformation driven by relentless innovation and enhanced patient care imperatives. This report delves into the drivers behind the growing preference for advanced chemotherapy devices, spotlighting the increased focus on precision treatment and improved patient comfort. In-depth analysis in this summary uncovers key industry trends, technological breakthroughs, and the dynamic regulatory environment that is shaping the market. With rising cancer incidence and increasing demand for personalized healthcare solutions, organizations are rethinking and reinventing their therapeutic methods. This report provides stakeholders with a comprehensive narrative that outlines how the growing need for effective, patient-friendly treatments is catalyzing the development and adoption of state-of-the-art chemotherapy devices.

The market is marked by significant investments in research and development, leading to devices that are not only technologically advanced but also engineered to support greater clinical precision and enhanced safety profiles. This introductory overview sets the stage for an insightful journey into the various facets of the market, encouraging both industry experts and decision-makers to explore key factors that are directing current and future strategies in the chemotherapy device sector.

Transformative Shifts in the Medical Landscape

The evolution of the chemotherapy device market is driven by transformative shifts that are altering the conventional treatment paradigms. Today, advancements in medical technology - along with strategic collaborations between research institutions and manufacturers - have created a fertile environment for innovation. This evolution is characterized by a move from conventional, one-size-fits-all treatment regimens to personalized, adaptive approaches that meet the individual requirements of patients.

At the heart of this shift is the integration of digital technologies and data analytics, enhancing the precision and reliability of device performance. Innovations in miniaturization have paved the way for devices that are not only highly efficient but also portable, empowering clinicians to administer care in diverse settings. Furthermore, continuous improvements in design and functionality have resulted in reduced complications associated with device usage, thereby promoting greater adoption of next-generation treatment modalities.

These changes reflect the broader trend toward value-based care - a model that emphasizes improved outcomes, cost efficiency, and enhanced patient satisfaction. Together, these developments are witnessing a transformation in how treatments are delivered, creating a more dynamic and responsive healthcare system. The shift is supported by regulatory changes that increasingly prioritize innovation while ensuring patient safety, contributing to a robust environment for market growth. Through such integrative advancements, the industry is prepared to meet the challenges of tomorrow's healthcare demands with agility and informed precision.

In-Depth Segmentation Insights of the Device Market

A thorough examination of the market reveals a layered segmentation strategy that is crucial to understanding the diverse aspects of chemotherapy devices. When analyzing product type, the exploration encompasses critical segments such as catheters, implantable ports, infusion pumps, and needleless connectors. Notably, the catheter segment is examined through a nuanced lens by dissecting it into central venous catheters, peripheral catheters, and peripherally inserted central catheters. Similarly, the infusion pump category is expanded into sub-segments including ambulatory pumps, elastomeric pumps, syringe pumps, and volumetric pumps. This detailed product categorization is instrumental in addressing specific patient needs as well as improving clinical outcomes, demonstrating the commitment of manufacturers to precision and innovation.

The segmentation based on modality further enriches the market analysis, differentiating between portable devices and stationary devices. This classification highlights the technological advancements aimed at meeting diverse clinical situations, ranging from emergency interventions to routine long-term therapies in controlled environments. The extent of device portability is particularly significant as it influences the accessibility and convenience of treatments, thereby directly impacting patient adherence and comfort.

Another critical dimension of segmentation is based on application. Here, the market scrutiny extends to treatment protocols for various types of cancers, including breast cancer, colorectal cancer, leukemia, lung cancer, and prostate cancer. Each cancer type has unique clinical challenges and treatment approaches, requiring devices that are tailored to the specific medical and anatomical requirements. The analysis of applications underscores the importance of designing devices that not only support precise drug administration but also facilitate safe and efficient patient care throughout the treatment cycle.

Further segmentation focuses on the end user, an aspect that highlights the diversity in medical settings where chemotherapy devices are deployed. From ambulatory surgical centers to homecare settings and hospitals, the use of these devices adapts to varied healthcare delivery models. Each end user category presents its own operational needs and clinical expectations, demanding devices that blend efficiency with robust safety features. This segmentation framework allows manufacturers and healthcare providers to align their product offerings with the detailed demands of each healthcare setting, resulting in a more patient centric approach.

The integration of these segmentation insights provides a comprehensive view of the market. Each segment, with its unique sub-categories and specific clinical applications, plays a pivotal role in advancing the overall adoption and success of innovative chemotherapy devices. The nuanced interpretation of product type, modality, application, and end user highlights the market's sophistication and the broad spectrum of opportunities that lie ahead for industry stakeholders.

Based on Product Type, market is studied across Catheters, Implantable Ports, Infusion Pumps, and Needleless Connectors. The Catheters is further studied across Central Venous Catheters, Peripheral Catheters, and Peripherally Inserted Central Catheters. The Infusion Pumps is further studied across Ambulatory Pumps, Elastomeric Pumps, Syringe Pumps, and Volumetric Pumps.

Based on Modality, market is studied across Portable Devices and Stationary Devices.

Based on Application, market is studied across Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, and Prostate Cancer.

Based on End User, market is studied across Ambulatory Surgical Centers, Homecare Settings, and Hospitals.

Dynamic Regional Expansion Analysis

Geographic expansion remains a pivotal element of the market's growth, with significant opportunities emerging across various regions. A comprehensive regional analysis reveals that market dynamics vary considerably across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the focus on advanced healthcare infrastructure and the progressive integration of cutting-edge treatment practices continue to drive the adoption of innovative chemotherapy devices. This region's commitment to improving patient outcomes is also reflected in the strategic investments in digital health technologies and state-of-the-art medical equipment.

Europe, Middle East & Africa, on the other hand, present a diverse landscape marked by varying levels of healthcare infrastructure development. While some countries in Europe lean into established, highly regulated ecosystems, emerging economies in the Middle East and Africa are simultaneously catching up by investing in modern medical technologies. These regions are witnessing a transformation propelled by proactive policy measures and a growing emphasis on healthcare accessibility, ultimately paving the way for a broader adoption of sophisticated chemotherapy devices.

Lastly, the Asia-Pacific region stands out for its dynamic growth trajectory, supported by rapid technological advancements and increasing government initiatives aimed at modernizing healthcare delivery. In this region, the dual forces of a burgeoning patient population and rising awareness of innovative treatment solutions are fuelling market adoption. The diverse regulatory conditions and tailored healthcare models in Asia-Pacific further underscore the potential for significant market expansion, making it a focal area for device deployment strategies on a global scale.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Analysis

Navigating the competitive landscape involves a detailed examination of key industry players who are driving innovation and setting new standards in the development of chemotherapy devices. Leading companies in this space include those with longstanding industry presence as well as emerging innovators that continue to set benchmarks for quality and innovation. Established organizations such as AngioDynamics, Inc. and Avanos Medical, Inc. have played a pivotal role in integrating state-of-the-art technologies into their product lines, ensuring that their devices meet stringent safety and performance criteria. Other multinationals, including B. Braun SE, Baxter International, and Becton, Dickinson and Company, have consistently demonstrated robust innovation pipelines and a strong commitment to patient-centric healthcare solutions. These companies, alongside Belmont Medical, Inc. and CODAN Medizinische Gerate GmbH, continue to fortify the market with their technological advancements.

The competitive landscape is further enriched by players like Districlass Medical SA and F. Hoffmann-La Roche Ltd, whose efforts in R&D have driven significant enhancements in device efficacy and reliability. ICU Medical, Inc. and InfuSystems, Inc. have also contributed by expanding the range of available solutions, ensuring that the market is well-equipped to address the increasing complexity of cancer treatments. Firms such as Leventon S.A.U. and Micrel Medical Devices SA are gaining traction by focusing on niche segments, while Mindray Medical International Limited and Moog Inc. offer comprehensive device portfolios that cater to diverse clinical scenarios.

A noteworthy aspect of the market's competitive dynamics is the interplay between global leaders and regional innovators. Companies like Nipro Corporation, Omnicell Inc., and Poly Medicure Limited have made significant strides by tailoring their product offerings to meet localized demands. Additional contributions from Schiller AG, Smiths Group plc., Terumo Corporation, and ThermaSolutions enhance the market's depth by providing a wide array of technical solutions that are characterized by precision and operational effectiveness. Ypsomed AG and Zyno Medical LLC round out this competitive analysis by continuing to challenge industry norms and enhance device functionalities, thereby ensuring a continually evolving marketplace that is driven by patient needs, clinical demands, and technological breakthroughs.

The report delves into recent significant developments in the Chemotherapy Device Market, highlighting leading vendors and their innovative profiles. These include AngioDynamics, Inc., Avanos Medical, Inc., B. Braun SE, Baxter International,, Becton, Dickinson and Company, Belmont Medical, Inc., CODAN Medizinische Gerate GmbH, Districlass Medical SA, F. Hoffmann-La Roche Ltd, ICU Medical, Inc., InfuSystems, Inc., Leventon S.A.U., Micrel Medical Devices SA, Mindray Medical International Limited, Moog Inc., Nipro Corporation, Omnicell Inc., Poly Medicure Limited, Schiller AG, Smiths Group plc., Terumo Corporation, ThermaSolutions, Ypsomed AG, and Zyno Medical LLC.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to take strategic steps to ensure sustainable growth and to secure a competitive edge in this evolving market. First and foremost, continuous investment in research and development is critical to advancing device technologies that are both innovative and aligned with evolving clinical requirements. Leaders should focus on establishing robust collaborations that harness the power of interdisciplinary research, thereby fostering an environment where patient-centric solutions can be developed with precision and efficiency.

It is advisable for decision-makers to adopt a segmented approach that carefully considers the specific requirements of different product types, modalities, applications, and end users. Understanding the nuances of each market segment allows for the tailoring of solutions that address unique clinical challenges while optimizing patient outcomes. This strategic segmentation should guide product development as well as marketing and distribution strategies, ensuring that offerings are well-aligned with current industry needs.

Moreover, stakeholders should focus on geographic diversification as a growth lever. Expanding market presence across regions with varying levels of healthcare maturity and infrastructural advancements - such as the Americas, Europe, Middle East & Africa, and Asia-Pacific - can help to mitigate risks associated with market saturation in one particular area. Expanding into emerging markets where regulatory landscapes are evolving rapidly also presents an opportunity to capture early market share.

Additionally, in-depth competitor analysis remains a crucial component of strategic planning. Regularly monitoring the advancements made by industry leaders and innovators can provide insights that not only refine product offerings but also reveal emerging technological trends. Embracing competitive intelligence ensures that industry leaders can stay abreast of market movements, anticipate changes, and proactively adjust strategies to maintain a leadership position.

Finally, integrating feedback loops from clinical end users and frontline practitioners will further enable the refinement of existing devices and the development of innovative solutions that address real-world challenges. This iterative approach to product enhancement, coupled with a robust digital strategy for data analytics and market forecasting, will empower industry leaders to respond swiftly to market trends and patient needs. By adopting these strategic recommendations, stakeholders can drive innovation, optimize operational efficiency, and ensure a resilient market position in this dynamic landscape.

Conclusion: Strategic Direction for Market Success

The analysis presented in this report underscores a fundamental truth: the chemotherapy device market is undergoing a profound transformation, driven by a dedication to innovation, precision, and patient-centered care. The multi-faceted segmentation based on product types, modalities, applications, and end users has revealed the intricacies of a market that is both diverse and complex, yet unified by the goal of enhancing patient outcomes.

Regional dynamics further highlight opportunities for growth across various geographical areas, with regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific each offering unique challenges and opportunities. This global perspective reinforces the importance of navigating local nuances while leveraging global best practices. Meanwhile, the competitive landscape, marked by the contributions of leading and innovative companies, demonstrates that a commitment to technological excellence and patient safety is paramount in driving market success.

As the healthcare industry continues to shift towards value-based care, this report emphasizes that sustained investment in R&D, strategic market segmentation, active geographic expansion, and continuous competitive intelligence are critical strategies for future growth. The collaboration between clinicians, device manufacturers, and policy makers is vital in driving the development of devices that not only respond to the escalating demands of cancer therapies but also set new standards in clinical excellence.

In summary, this comprehensive overview serves as both a diagnostic and prognostic tool for industry leaders, capturing the current state of the market while providing a forward-looking blueprint for sustained growth and competitive differentiation. The strategic insights compiled herein empower stakeholders to make informed decisions that align with the rapidly changing dynamics of the healthcare sector.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cancer and expanding diagnosis rates globally
    • 5.1.1.2. Rising healthcare expenditure for better access to advanced medical treatments
    • 5.1.1.3. Growing emphasis on personalized and targeted therapy approaches
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of advanced chemotherapy devices and availability of alternative treatment technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in the development of targeted chemotherapy delivery systems
    • 5.1.3.2. Integration of artificial intelligence and machine learning in chemotherapy devices
  • 5.1.4. Challenges
    • 5.1.4.1. Safety concerns and potential adverse side effects of chemotherapy devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Rising demand for peripheral catheters owing to the ease of insertion and minimal invasiveness
  • 5.2.2. End User: Growing usage of chemotherapy devices in ambulatory surgical centers to support minimally invasive procedures
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Chemotherapy Device Market, by Product Type

• 6.1. Introduction
• 6.2. Catheters
  • 6.2.1. Central Venous Catheters
  • 6.2.2. Peripheral Catheters
  • 6.2.3. Peripherally Inserted Central Catheters
• 6.3. Implantable Ports
• 6.4. Infusion Pumps
  • 6.4.1. Ambulatory Pumps
  • 6.4.2. Elastomeric Pumps
  • 6.4.3. Syringe Pumps
  • 6.4.4. Volumetric Pumps
• 6.5. Needleless Connectors

7. Chemotherapy Device Market, by Modality

• 7.1. Introduction
• 7.2. Portable Devices
• 7.3. Stationary Devices

8. Chemotherapy Device Market, by Application

• 8.1. Introduction
• 8.2. Breast Cancer
• 8.3. Colorectal Cancer
• 8.4. Leukemia
• 8.5. Lung Cancer
• 8.6. Prostate Cancer

9. Chemotherapy Device Market, by End User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Homecare Settings
• 9.4. Hospitals

10. Americas Chemotherapy Device Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Chemotherapy Device Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Chemotherapy Device Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Novocure received FDA approval of Optune Lua wearable tumor-zapping device transforms lung cancer treatment
  • 13.3.2. Luminate Medical secures USD 15 million Series A funding
  • 13.3.3. InfuSystem and Sanara MedTech secure exclusive U.S. distribution and joint venture rights for the ChemoMouthpiece oral cryotherapy device
  • 13.3.4. The merger between MOC and HOC-Vedanta enhances India's cancer treatment with advanced chemotherapy devices
  • 13.3.5. MIT-founded launched an innovative device for non-invasive monitoring of chemotherapy patients
  • 13.3.6. Advent International and Warburg Pincus acquired Baxter's Biopharma Solutions
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AngioDynamics, Inc.
• 2. Avanos Medical, Inc.
• 3. B. Braun SE
• 4. Baxter International,
• 5. Becton, Dickinson and Company
• 6. Belmont Medical, Inc.
• 7. CODAN Medizinische Gerate GmbH
• 8. Districlass Medical SA
• 9. F. Hoffmann-La Roche Ltd
• 10. ICU Medical, Inc.
• 11. InfuSystems, Inc.
• 12. Leventon S.A.U.
• 13. Micrel Medical Devices SA
• 14. Mindray Medical International Limited
• 15. Moog Inc.
• 16. Nipro Corporation
• 17. Omnicell Inc.
• 18. Poly Medicure Limited
• 19. Schiller AG
• 20. Smiths Group plc.
• 21. Terumo Corporation
• 22. ThermaSolutions
• 23. Ypsomed AG
• 24. Zyno Medical LLC.